E.i. Dupont De Nemours and Company

Colgate Palmolive Company

Genencor International, Inc.

Danisco US Inc.

Sharon Loretta Haynie

Robert DiCosimo

Shaotang Yuan

Guofeng Xu

Mark Scott Payne

Jennifer Gronlund

Gregory Marshall Whited

Jeff P Pucci

Lisa Anne Laffend

Mark Emptage

Kari A Fosser

Suman Kumar Chopra

Venda Porter Maloney

Paloma Pimenta

Dennis Ontumi

Rajnish Kohli

Anthony Arthur Gatenby

Junhong Mao

Jodie Parker

John Thomas Gannon

Amy Kuang-Hua Hsu

Jeff Pucci

Greg Whited

Hong Peng Wang

Vasantha Nagarajan

Stephen K Picataggio

Pierre E Rouviere

Arie Ben-Bassat

Donald Eugene Trimbur

Charles Edwin Nakamura

Dotsevi Y Sogah

David J Lowe

Tina K Van Dyk

Ramesh V Nair

Tanja Maria Gruber

Fateme Sima Sariaslani

Scott D Cunningham

Henry Kobsa

Lixuan Lisa Huang

Jeffrey David Cohen

Mureo Kaku

Maria R Diaz-Torres

Lorraine Winona Wagner

Michael H Scholla

Lisa L Huang

Arthur N Roe

Ben A Bulthuis

Carl W Erkenbrecher, Jr

Michael J Kelley

Lisa C Grimminger

Richard D La Reau

Lisa A Butterick

Robert J Trotman

Richard D Lareau

Stephen Kenneth Picataggio

Hong Wang

Described herein are oral care compositions, comprising a peroxydone complex, a dispersant, and a polyvinylpyrrolidone copolymer structure-building agent.

Oral care compositions

An oral care composition, including a catalyzing enzyme and an anhydrous matrix configured to at least partially stabilize the catalyzing enzyme, wherein the anhydrous matrix includes a source of hydrogen peroxide, an acyl donor, a non-aqueous anhydrous liquid, and a surfactant mixture including sodium lauryl sulfate (SLS), Betaine, and a poloxamer.

An oral care composition, including a non-aqueous dispersant and an amphiphilic copolymer structure-building agent.

Oral care composition

An oral care composition, including a non-aqueous dispersant and a fatty acid structure-building agent.

An oral care composition including an enzyme and an anhydrous matrix that at least partially stabilizes the enzyme. The anhydrous matrix includes a source of hydrogen peroxide, an acyl donor, a non-aqueous anhydrous liquid, and a thickener.

Oral care compositions and methods for whitening teeth

An oral care composition including an orally acceptable vehicle is disclosed. The orally acceptable vehicle includes a source of hydrogen peroxide, an acyl donor, and an enzyme that catalyzes the generation of peracetic acid between the source of hydrogen peroxide and the acyl donor.

Disclosed herein are compositions and methods to treat an oral cavity surface with a peracid-based benefit agent. The peracid benefit agent can be use for oral surface bleaching, whitening, disinfecting, destaining, deodorizing, decreasing or removing biofilm, and combinations thereof. The peracid is enzymatically generated from a carboxylic acid ester substrate using a CE-7 carbohydrate esterase having perhydrolytic activity (perhydrolase) in the presence of a source of peroxygen. A fusion protein comprising the perhydrolase coupled to a peptidic component having affinity for an oral cavity surface, either directly or through an optional linker, may be used to target the perhydrolytic activity to the oral cavity surface.

Enzymatic peracid generation for use in oral care products

TAL cell biocatalyst was immobilized in alginate cross-linked beads using low concentrations of glutaraldehyde. The biocatalyst beads have highly stable TAL activity and mechanical strength such that they withstand prolonged recycling in production of pHCA.

Immobilized TAL biocatalyst for production of para-hydroxycinnamic acid

The present invention provides an improved method for the biological production of 1,3-propanediol from a fermentable carbon source in a single microorganism. In one aspect of the present invention, an improved process for the conversion of glucose to 1,3-propanediol is achieved by the use of antransformed with thedha regulon genes dhaR, orfY, dhaT, orfX, orfW, dhaB1, dhaB2, dhaB3, and orfZ, all these genes arranged in the same genetic organization as found in wild type. In another aspect of the present invention, an improved process for the production of 1,3-propanediol from glucose using a recombinantcontaining genes encoding a G3PDH, a G3P phosphatase, a dehydratase, and a dehydratase reactivation factor compared to an identical process using a recombinantcontaining genes encoding a G3PDH, a G3P phosphatase, a dehydratase, a dehydratase reactivation factor and a 1,3-propanediol oxidoreductase (dhaT). The dramatically improved process relies on the presence inof a gene encoding a non-specific catalytic activity sufficient to convert 3-hydroxypropionaldehyde to 1,3-propanediol.

Process for the biological production of 1,3-propanediol with high titer

Growing community of inventors

Philadelphia, PA, United States of America

Sharon Loretta Haynie